Allergan Unlimited Company, formerly Allergan Limited, is an Ireland-based pharmaceutical company. The Company is focused on developing, manufacturing and commercializing branded pharmaceutical, device, biologic, surgical and regenerative medicine products for patients around the world. The Company's products primarily focus on four key therapeutic areas, including medical aesthetics, eye care, central nervous system and gastroenterology.

Employees

Sector

Pharmaceuticals

More about the company

Delayed NYSE			5-day change	1st Jan Change
- ^USD	-.--%		+1.73%	+0.97%

Sep. 17	Allergan Aesthetics Presents New Clinical Data Evaluating Skin Quality Improvements in Individuals Taking Medical Weight Loss Medications	CI
Sep. 15	Allergan Aesthetics Introduces the FACTS Principles for Exosome-Based Skincare Technologies	CI

Market Cap	63.66B 56.85B 52.89B 48.11B 90.83B 6,161B 91.22B 637B 249B 3,141B 239B 234B 10,080B	P/E 2018	-8.76x	P/E 2019	-11.9x
Enterprise Value	80.96B 72.31B 67.27B 61.18B 116B 7,836B 116B 810B 317B 3,995B 304B 297B 12,820B	EV / Sales 2018	4.24x	EV / Sales 2019	4.98x
Free-Float	99.9%	Yield 2018	2.15%	Yield 2019	1.55%

Sep. 17	Allergan Aesthetics Presents New Clinical Data Evaluating Skin Quality Improvements in Individuals Taking Medical Weight Loss Medications	CI
Sep. 15	Allergan Aesthetics Introduces the FACTS Principles for Exosome-Based Skincare Technologies	CI
Sep. 01	Allergan Aesthetics Launches Skinmedica Barrier Calming Cream and Ha5 Hydra Collagen Facial Mist	CI
Apr. 07	Allergan Aesthetics Opens New Ami Training Center in Austin	CI
Mar. 31	Allergan Aesthetics Announces Fourth Annual CoolMonth With Deals On CoolSculpting	CI
Mar. 30	Allergan Aesthetics Presents Findings on Safety and Efficacy of Repeat Trenibote Treatments and Data on Medical Weight Loss Aesthetics Patient Behaviors At the 2026 American Academy of Dermatology Meeting	CI
Mar. 19	Allergan Aesthetics Reveals Evolution in Approach to Modern Aesthetic Treatments with Comprehensive Global Survey and New Educational Solutions	CI
Mar. 04	Allergan Aesthetics Shares Medical Weight Loss Data and the Changing Profile of Patients	CI
Nov. 12	Allergan Aesthetics Unveils New Data at 2025 American Society for Dermatologic Surgery Annual Meeting Showcasing Transformative Innovation and Portfolio Excellence	CI
25-09-25	AllAllergan Aesthetics to Showcase Multimodal Treatment Approach and Continued Commitment to Skin Quality At AMWC Dubai	CI
25-08-19	Allergan Aesthetics Unveils Its Newest Hydration Hero	CI
25-06-30	U.S. Food and Drug Administration Accepts for Review Allergan Aesthetics Premarket Approval Application for Skinvive by Juvederm for the Improvement of Neck Appearance	CI
25-02-12	Allergan Aesthetics to Launch Three New Training Centers in the U.S. Expanding Access to High Quality Aesthetics Training	CI

24-04-01	Court Dismisses Class Action Against Biopharmaceutical Company For Failing To Disclose Progress Of Competitor; Second Circuit Affirms Dismissal Of Putative Class Action Against Allergan; Eleventh Circuit Affirms That "Toxic" Lender Qualified As A "Dealer" Under The Exchange Act Due To High-Volume Trading; Delaware Court Of Chancery Invalidates Governance Rights In Stockholder Agreement	AQ
22-04-20	Allergan, an AbbVie Company, to Present New Data from its Eye Care Portfolio at the 2022 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting	AQ
22-04-06	Allergan, an AbbVie Company, Announces Positive Topline Phase 3 Results Evaluating Investigational Twice-Daily Administration of VUITY 1.25% in Adults with Age-Related Blurry Near Vision	AQ
22-03-22	AbbVie and Allergan Aesthetics to Present New Research Across Dermatology Portfolio at 2022 AAD Annual Meeting	AQ
21-12-10	Allergan - VUITY 1.25%, the First and Only FDA-Approved Eye Drop to Treat Age-Related Blurry near Vision, is Now Available	AQ

Allergan plc Stock

Stocks

AGN

IE00BY9D5467

Pharmaceuticals

Valuation: Allergan plc

Latest news: Allergan plc

Press Releases: Allergan plc

News in other languages: Allergan plc

Managers and Directors: Allergan plc

Latest insider transactions

Other Pharmaceuticals

Financials

Company Profile

21-04-20	Planète Bourse : La revue de presse du mardi 20 avril 2021
20-05-07	EN DIRECT DES MARCHES : Air France KLM, ArcelorMittal, Legrand, Natixis, Peugeot, Eurofins, Zalando, Facebook...
20-05-07	La Chine repart, mais Washington veille
20-05-06	EN DIRECT DES MARCHES : Danone, Sanofi, Crédit Agricole, Arkema, Neoen, Eurofins, BMW, Novo Nordisk...
20-05-06	Trump franchit le Rubicon

Director	Title	Age	Since
Scott Reents BRD	Director/Board Member	-	2020-05-07
Ryan Quigley BRD	Director/Board Member	-	2020-05-07
Andres Rodrigo BRD	Director/Board Member	-	2020-05-07

Date	Insider	Type	Main position	Quantity	% Market Cap.
5/8/20	James D'Arecca	Issuer sale	Controller/Auditor	19,495	0.0059%
5/8/20	Adriane Brown	Issuer sale	Director	2,916	0.0009%
5/8/20	Matthew Walsh	Issuer sale	Chief Financial Officer	67,678	0.0206%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ALLERGAN PLC	-.--%	+1.73%	-	-	63.66B
ELI LILLY AND COMPANY	+0.34%	+3.39%	+44.23%	+93.59%	1,051B
JOHNSON & JOHNSON	+0.45%	+3.72%	+37.42%	+67.81%	630B
ABBVIE INC.	+1.11%	+4.99%	+21.16%	+88.15%	489B
MERCK & CO., INC.	-0.47%	+3.78%	+68.97%	+39.79%	359B
ROCHE HOLDING AG	+0.63%	+3.07%	+23.96%	+42.30%	344B
NOVARTIS AG	+0.42%	+2.54%	+14.30%	+34.13%	272B
ASTRAZENECA PLC	-0.12%	+1.67%	-6.00%	+7.55%	246B
AMGEN INC.	+0.20%	+3.03%	+41.99%	+45.66%	224B
GILEAD SCIENCES, INC.	-0.65%	+3.84%	+27.05%	+95.66%	187B
Average	+0.10%	+2.75%	+30.34%	+57.18%	386.74B
Weighted average by Cap.	+0.24%	+2.91%	+34.27%	+66.34%

	2018	2019
Net sales	15.79B 14.1B 13.12B 11.93B 22.53B 1,528B 22.62B 158B 61.85B 779B 59.28B 57.99B 2,500B	16.09B 14.37B 13.37B 12.16B 22.96B 1,557B 23.06B 161B 63.03B 794B 60.42B 59.1B 2,548B
Net income	-5.1B -4.55B -4.23B -3.85B -7.27B -493B -7.3B -50.96B -19.97B -251B -19.14B -18.72B -807B	-5.27B -4.71B -4.38B -3.98B -7.52B -510B -7.55B -52.71B -20.65B -260B -19.79B -19.36B -835B
Net Debt	21.89B 19.55B 18.19B 16.54B 31.23B 2,119B 31.37B 219B 85.76B 1,080B 82.2B 80.41B 3,466B	17.3B 15.45B 14.38B 13.08B 24.69B 1,675B 24.8B 173B 67.8B 854B 64.98B 63.56B 2,740B